Alphatec Holdings (NASDAQ: ATEC) stock was up on Monday, as the medical device company announced preliminary Q3 results. The company expects its revenues to range between $89 million and $90 million, 42% to 43% higher year-over-year.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
At the end of the third quarter, ATEC had a cash balance of around $106 million.
Alphatec also raised its FY22 revenue guidance and now expects revenues to grow by 40% versus its earlier guidance of 34% growth.
What are the Predictions for Alphatec Holdings Stock?
Wall Street analysts are bullish about ATEC stock, with a Strong Buy consensus rating based on five Buys and one Hold.
The average price forecast for ATEC stock is $13.58, implying upside potential of 38.8% at current levels.
